In summary, we provide initial real-world evidence of reduced alcohol consumption in people with obesity taking Semaglutide or Tirzepatide medications, suggesting potential efficacy for treatment in AUD comorbid with obesity. Note: Beyond what is publicly available today, several studies from established research groups showing substantial anti-addictive effects have been submitted to journals and will be published in mid-2024
Injection protocol Retatrutide is administered as a subcutaneous injection once weekly
Drinking alcohol with this medicine can cause side effects
Glutathione is a tripeptide(small, three component protein) composed of the three amino acids (protein building blocks) glutamic acid, cysteine and glycine
It is clinical information
Unfortunately, if these medications are stopped, patients regain almost 70% of their lost weight on average within one year